NEW ALBANY

CVG Announces Participation in the Sidoti Virtual Investor Conference

Retrieved on: 
Tuesday, January 17, 2023
CVG, Conference, Webcast, Sidoti, Management, Financial adviser

NEW ALBANY, Ohio, Jan. 17, 2023 (GLOBE NEWSWIRE) -- CVG (NASDAQ: CVGI) announced today that Harold Bevis, President and Chief Executive Officer, and Andy Cheung, Executive Vice President and Chief Financial Officer, will present virtually at the Sidoti January Micro-Cap Virtual Conference on January 19, 2023, at 10:45 a.m.

Key Points: 
  • NEW ALBANY, Ohio, Jan. 17, 2023 (GLOBE NEWSWIRE) -- CVG (NASDAQ: CVGI) announced today that Harold Bevis, President and Chief Executive Officer, and Andy Cheung, Executive Vice President and Chief Financial Officer, will present virtually at the Sidoti January Micro-Cap Virtual Conference on January 19, 2023, at 10:45 a.m.
  • A link to the webcast can be accessed through the investor section of the Company’s website at cvgrp.com .
  • The presentation materials will be posted on the Company Website and be archived there for a period of 30 days.
  • Management will also meet virtually with investors registered for the conference.

Abercrombie & Fitch Co. Increases Fourth Quarter Sales and Operating Margin Outlook Based on Better-Than-Expected Holiday Sales

Retrieved on: 
Monday, January 9, 2023
Security (finance), Information, Failure, Press release, Abercrombie, Terrorism, Conference, Abercrombie & Fitch Co. v. Hunting World, Inc., ICR, Privacy, Risk management

(2) The current fourth quarter outlook reflects an adverse impact of approximately 210 basis points from foreign currency, down from approximately 300 basis points in the previous outlook.

Key Points: 
  • (2) The current fourth quarter outlook reflects an adverse impact of approximately 210 basis points from foreign currency, down from approximately 300 basis points in the previous outlook.
  • (3) The current full year outlook reflects an adverse impact of approximately 220 basis points from foreign currency, down from approximately 250 basis points in the previous outlook.
  • The company will be participating in meetings with investors and analysts at the ICR XChange Conference to be held on January 9-10, 2023.
  • Words such as “estimate,” “project,” “plan,” “believe,” “expect,” “anticipate,” “intend,” “should,” “are confident,” “will,” “could,” “outlook,” and similar expressions may identify forward-looking statements.

Harold Bevis Joins the Committee for Economic Development (CED) as Trustee

Retrieved on: 
Friday, January 6, 2023
Government, CVG, Business administration, Plant, Organization, GE, Commercial Vehicle Group, Booz Allen Hamilton, Committee for Economic Development, Special Olympics, Public policy, Iowa State University, Policy, Family, Committee, The Conference Board, Columbia University, Tier 2, Conference, Trade, Army, Economic development, Trustee, Management, Science

NEW ALBANY, Ohio, Jan. 06, 2023 (GLOBE NEWSWIRE) -- Harold Bevis, President and Chief Executive Officer of CVG, has joined the Committee for Economic Development as a Trustee.

Key Points: 
  • NEW ALBANY, Ohio, Jan. 06, 2023 (GLOBE NEWSWIRE) -- Harold Bevis, President and Chief Executive Officer of CVG, has joined the Committee for Economic Development as a Trustee.
  • Mr. Bevis will serve on the Trade and Economic Globalization Committee as well as the Technology and Innovation Committee.
  • The Committee for Economic Development is the public policy center of The Conference Board.
  • Harold Bevis is the President and Chief Executive Officer of Commercial Vehicle Group (NASDAQ:CVGI).

CVG Announces Participation in the Sidoti Virtual Small-Cap Investor Conference

Retrieved on: 
Thursday, December 1, 2022
Engineering, CVG, Internet, Sidoti, Webcast, Conference

A link to the webcast can be accessed through the investor section of the Companys website at cvgrp.com .

Key Points: 
  • A link to the webcast can be accessed through the investor section of the Companys website at cvgrp.com .
  • The presentation materials will be posted on the Company Website and be archived there for a period of 30 days.
  • Management will also meet virtually with investors registered for the conference.
  • At CVG, we deliver real solutions to complex design, engineering and manufacturing problems while creating positive change for our customers, industries, and communities we serve.

Noble Capital Markets Initiates Equity Research Coverage on Commercial Vehicle Group (CVG)

Retrieved on: 
Thursday, December 1, 2022
Internet, Engineering, Noble, CVG, Research, Capital market, FINRA, News, Security (finance)

NEW ALBANY, Ohio, Dec. 01, 2022 (GLOBE NEWSWIRE) -- CVG (NASDAQ: CVGI), a diversified industrial products and services company, is pleased to announce that Noble Capital Markets has initiated company-sponsored equity research coverageon the company.The full report by Noble Capital Markets Senior Research Analyst Joe Gomes, as well as news and advanced market data on CVG, is available on Channelchek.

Key Points: 
  • NEW ALBANY, Ohio, Dec. 01, 2022 (GLOBE NEWSWIRE) -- CVG (NASDAQ: CVGI), a diversified industrial products and services company, is pleased to announce that Noble Capital Markets has initiated company-sponsored equity research coverageon the company.The full report by Noble Capital Markets Senior Research Analyst Joe Gomes, as well as news and advanced market data on CVG, is available on Channelchek.
  • Noble Capital Markets, Inc. was incorporated in 1984 as a full-service SEC / FINRA registered broker-dealer, dedicated exclusively to serving underfollowed small / microcap companies through investment banking, wealth management, trading & execution, and equity research activities.
  • Over the past 37 years, Noble has raised billions of dollars for these companies and published more than 45,000 equity research reports.
  • Research on Channelchek is provided by Noble Capital Markets, Inc., an SEC / FINRA registered broker-dealer since 1984. www.channelchek.com email: [email protected]

RxLightning Debuts Revolutionary MedAccess Ecosystem

Retrieved on: 
Thursday, November 17, 2022
Ecosystem, Physician, Pharmacy, Telescopic sight, Medicine

New Albany, Indiana--(Newsfile Corp. - November 17, 2022) - Health tech start-up RxLightning today debuted its MedAccess Ecosystem, a first-of-its-kind platform that connects all stakeholders across the complex, disconnected universe that is specialty medication access in America and provides never-before realized visibility into the patient journey for the entire ecosystem of specialty pharmacy care.

Key Points: 
  • New Albany, Indiana--(Newsfile Corp. - November 17, 2022) - Health tech start-up RxLightning today debuted its MedAccess Ecosystem, a first-of-its-kind platform that connects all stakeholders across the complex, disconnected universe that is specialty medication access in America and provides never-before realized visibility into the patient journey for the entire ecosystem of specialty pharmacy care.
  • Founded in New Albany, Indiana in 2020, RxLightning enables physicians to accelerate patient access to their preferred specialty therapies.
  • The RxLightning MedAccess platform was designed for physicians and their clinical team to re-imagine the entire specialty medication experience without paper forms or fax machines.
  • With RxLightning, access to life-enhancing and life-saving medications is measured in hours, not days or weeks.

Abercrombie & Fitch Co. Announces Board Of Directors Leadership Transition

Retrieved on: 
Tuesday, November 22, 2022
Abercrombie, Individual, Skin, Harris v. Blockbuster, Inc., Press release, Audit, Chairperson, Advance Auto Parts, Non-executive director, Dixie, Life, Social media, ANF, Learning, IPO, Movement, Charli, Abercrombie & Fitch, Fran, Executive Committee, National Executive Committee of the Labour Party, Blockbuster, Security (finance), NYSE, Abercrombie & Fitch Co. v. Hunting World, Inc., Happiness, Committee on Finance, Woman, Management, Fashion

NEW ALBANY, Ohio, Nov. 22, 2022 (GLOBE NEWSWIRE) -- Abercrombie & Fitch Co. (NYSE: ANF), a leading, global omni-channel specialty retailer of apparel and accessories, today announced a change in its Board of Directors as part of a leadership transition. After five years in the position and in connection with his plans to retire as a Director, Terry Burman will step down as Chairperson of the Board at the conclusion of the company’s fiscal year ending on January 28, 2023, and will not stand for re-election at the Company’s 2023 Annual Meeting of Stockholders. Nigel Travis, current Director and Chair of the Nominating and Board Governance Committee of the Board, will assume the role of Chairperson effective January 28, 2023.

Key Points: 
  • The company is in a dramatically different place than we were when he joined the Board in 2014.
  • Horowitz concluded, We are fortunate to have a deep leadership bench on our Board of Directors.
  • Mr. Travis also currently serves as on the board of directors of Advance Auto Parts, Inc. (August 2018 to present).
  • About Abercrombie & Fitch Co.:
    Abercrombie & Fitch Co.(NYSE: ANF) is a leading, global, omnichannel specialty retailer of apparel and accessories for men, women and kids through five renowned brands.

RxLightning Announces the Appointment of Jared Klingeisen as Chief Operating Officer

Retrieved on: 
Thursday, November 3, 2022
Physician, COO, Pharmaceutical industry, Telescopic sight

New Albany, Indiana--(Newsfile Corp. - November 3, 2022) - RxLightning today announced that Jared Klingeisen has been appointed as the company's Chief Operating Officer.

Key Points: 
  • New Albany, Indiana--(Newsfile Corp. - November 3, 2022) - RxLightning today announced that Jared Klingeisen has been appointed as the company's Chief Operating Officer.
  • To view the full announcement, including downloadable images, bios, and more, click here .
  • Founded in New Albany, Indiana in 2020, RxLightning enables physicians to accelerate patient access to their preferred specialty therapies.
  • The RxLightning MedAccess platform was designed for physicians and their clinical team to re-imagine the entire specialty medication experience without paper forms or fax machines.